On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
rare
Japan second biggest drugmaker Astellas Pharma to acquire Audentes Therapeutics for $3 billion
Japan’s Astellas Pharma Inc is set to acquire Audentes Therapeutics Inc for around $3 billion in a deal aimed at boosting genetic medicines – a key area of growth. Gene therapies are one of the hottest areas of drug research…. Read More ›